← Unusual insider activity · Company hub
VRTX Vertex Pharmaceuticals Inc
Insider figures are trailing 90 days, open-market Form 4 only. Institutional figures are the latest reported quarter. These windows are not simultaneous.
-$2.3M net selling - trailing 90 days
0 buyers - 4 unique sellers
Historical context: No open-market activity in Aug 2026 — insiders traded in 16 of the last 23 months (limited history)
6 accumulating - 7 trimming - 1 unchanged
14 comparable institutions - Q2 2026
open-market Form 4 only - grants, exercises, tax withholding excluded. ~ derived from SEC-reported shares x price.
Who is responsible
| Insider | Role | Net activity | Rows |
|---|---|---|---|
| McKechnie Duncan | EVP, Chief Commercial Officer | -~$0.8M | 1 |
| Tatsis Ourania | EVP, Chief Reg. & Quality Off. | -~$0.8M | 1 |
| Liu Joy | EVP and Chief Legal Officer | -~$0.4M | 1 |
| Bozic Carmen | EVP and CMO | -~$0.3M | 1 |
Transactions
| Date | Insider | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 7/2/2026 | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | S | -1500 | 524.99 | ~$0.8M |
| 7/2/2026 | McKechnie Duncan | EVP, Chief Commercial Officer | S | -1541 | 519 | ~$0.8M |
| 7/1/2026 | Liu Joy | EVP and Chief Legal Officer | S | -828 | 502.71 | ~$0.4M |
| 6/26/2026 | Bozic Carmen | EVP and CMO | S | -596 | 482.5 | ~$0.3M |
| 6/18/2026 | Bozic Carmen | EVP and CMO | S | -1020 | 462.17 | ~$0.5M |
| 6/15/2026 | Bozic Carmen | EVP and CMO | S | -4062 | 450 | ~$1.8M |
| 6/5/2026 | Bozic Carmen | EVP and CMO | S | -1745 | 450 | ~$0.8M |
| 6/1/2026 | Liu Joy | EVP and Chief Legal Officer | S | -828 | 439.91 | ~$0.4M |
| 5/29/2026 | Bozic Carmen | EVP and CMO | S | -1974 | 450 | ~$0.9M |
| 5/15/2026 | Bozic Carmen | EVP and CMO | S | -1354 | 453.45 | ~$0.6M |
| 5/15/2026 | Bunnage Mark E. | EVP, Chief Scientific Officer | S | -33 | 453.45 | ~$15K |
| 5/12/2026 | Bozic Carmen | EVP and CMO | S | -6988 | 450 | ~$3.1M |
| 5/4/2026 | Bhatia Sangeeta N. | — | S | -318 | 423.73 | ~$0.1M |
| 5/1/2026 | Liu Joy | EVP and Chief Legal Officer | S | -1104 | 425.02 | ~$0.5M |
| 4/1/2026 | Liu Joy | EVP and Chief Legal Officer | S | -978 | 449.17 | ~$0.4M |
| 3/27/2026 | Bozic Carmen | EVP and CMO | S | -2329 | 450.95 | ~$1.1M |
| 3/13/2026 | Bozic Carmen | EVP and CMO | S | -2329 | 481.79 | ~$1.1M |
| 3/11/2026 | McKechnie Duncan | EVP, Chief Commercial Officer | S | -2633 | 498.42 | ~$1.3M |
| 3/4/2026 | McKechnie Duncan | EVP, Chief Commercial Officer | S | -2437 | 475.3 | ~$1.2M |
| 3/2/2026 | Liu Joy | EVP and Chief Legal Officer | S | -892 | 495.96 | ~$0.4M |
| 2/27/2026 | Kewalramani Reshma | CEO & President | 13 reported sale rows | 40000 | — | ~$19.7M |
| 2/27/2026 | Kewalramani Reshma | CEO & President | S | -2725 | 490.54 | ~$1.3M |
| 2/27/2026 | Kewalramani Reshma | CEO & President | S | -400 | 479.75 | ~$0.2M |
| 2/27/2026 | Kewalramani Reshma | CEO & President | S | -120 | 481.5 | ~$58K |
| 2/27/2026 | Kewalramani Reshma | CEO & President | S | -240 | 482.84 | ~$0.1M |
| 2/27/2026 | Kewalramani Reshma | CEO & President | S | -2510 | 487.13 | ~$1.2M |
| 2/27/2026 | Kewalramani Reshma | CEO & President | S | -3278 | 488.27 | ~$1.6M |
| 2/27/2026 | Kewalramani Reshma | CEO & President | S | -460 | 489.32 | ~$0.2M |
| 2/27/2026 | Kewalramani Reshma | CEO & President | S | -949 | 491.3 | ~$0.5M |
| 2/27/2026 | Kewalramani Reshma | CEO & President | S | -2520 | 493.29 | ~$1.2M |
| 2/27/2026 | Kewalramani Reshma | CEO & President | S | -3498 | 494.33 | ~$1.7M |
| 2/27/2026 | Kewalramani Reshma | CEO & President | S | -15580 | 495.38 | ~$7.7M |
| 2/27/2026 | Kewalramani Reshma | CEO & President | S | -5995 | 496.16 | ~$3.0M |
| 2/27/2026 | Kewalramani Reshma | CEO & President | S | -1725 | 496.95 | ~$0.9M |
| 2/27/2026 | Bozic Carmen | EVP and CMO | S | -2329 | 480.31 | ~$1.1M |
| 2/26/2026 | Ambrose Kristen | SVP & Chief Accounting Officer | S | -357 | 483.36 | ~$0.2M |
| 2/25/2026 | McKechnie Duncan | EVP, Chief Commercial Officer | 2 reported sale rows | 4910 | — | ~$2.4M |
| 2/25/2026 | McKechnie Duncan | EVP, Chief Commercial Officer | S | -2410 | 489 | ~$1.2M |
| 2/25/2026 | McKechnie Duncan | EVP, Chief Commercial Officer | S | -2500 | 486.35 | ~$1.2M |
| 2/25/2026 | Sachdev Amit | EVP Chief Patient & Ext Af Off | S | -1846 | 486.35 | ~$0.9M |
| 2/25/2026 | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | S | -260 | 486.35 | ~$0.1M |
| 2/25/2026 | Biller Jonathan | EVP and Chief Legal Officer | S | -945 | 486.35 | ~$0.5M |
| 2/25/2026 | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off. | S | -668 | 486.35 | ~$0.3M |
| 2/25/2026 | Ambrose Kristen | SVP & Chief Accounting Officer | S | -223 | 486.35 | ~$0.1M |
| 2/25/2026 | Bunnage Mark E. | EVP, Chief Scientific Officer | S | -620 | 486.35 | ~$0.3M |
| 2/19/2026 | Sachdev Amit | EVP Chief Patient & Ext Af Off | 8 reported sale rows | 58613 | — | ~$27.5M |
| 2/19/2026 | Sachdev Amit | EVP Chief Patient & Ext Af Off | S | -4237 | 471.43 | ~$2.0M |
| 2/19/2026 | Sachdev Amit | EVP Chief Patient & Ext Af Off | S | -11712 | 470.54 | ~$5.5M |
| 2/19/2026 | Sachdev Amit | EVP Chief Patient & Ext Af Off | S | -7241 | 469.61 | ~$3.4M |
| 2/19/2026 | Sachdev Amit | EVP Chief Patient & Ext Af Off | S | -19662 | 468.57 | ~$9.2M |
| 2/19/2026 | Sachdev Amit | EVP Chief Patient & Ext Af Off | S | -10263 | 467.75 | ~$4.8M |
| 2/19/2026 | Sachdev Amit | EVP Chief Patient & Ext Af Off | S | -1848 | 465.8 | ~$0.9M |
| 2/19/2026 | Sachdev Amit | EVP Chief Patient & Ext Af Off | S | -2730 | 465.05 | ~$1.3M |
| 2/19/2026 | Sachdev Amit | EVP Chief Patient & Ext Af Off | S | -920 | 463.91 | ~$0.4M |
| 2/18/2026 | Biller Jonathan | EVP and Chief Legal Officer | S | -1244 | 473.68 | ~$0.6M |
| 2/18/2026 | Ambrose Kristen | SVP & Chief Accounting Officer | S | -638 | 473.68 | ~$0.3M |
| 2/18/2026 | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off. | S | -817 | 473.68 | ~$0.4M |
| 2/18/2026 | Bunnage Mark E. | EVP, Chief Scientific Officer | S | -1182 | 473.68 | ~$0.6M |
| 2/18/2026 | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | S | -368 | 473.68 | ~$0.2M |
| 2/17/2026 | Ambrose Kristen | SVP & Chief Accounting Officer | S | -1557 | 489.46 | ~$0.8M |
| 2/17/2026 | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | S | -609 | 489.46 | ~$0.3M |
| 2/17/2026 | Bunnage Mark E. | EVP, Chief Scientific Officer | S | -2437 | 489.46 | ~$1.2M |
| 2/17/2026 | Biller Jonathan | EVP and Chief Legal Officer | S | -2476 | 489.46 | ~$1.2M |
| 2/17/2026 | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off. | S | -2031 | 489.46 | ~$1.0M |
| 2/13/2026 | Biller Jonathan | EVP and Chief Legal Officer | S | -988 | 499 | ~$0.5M |
| 2/13/2026 | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | S | -1500 | 499.99 | ~$0.7M |
| 2/13/2026 | Bhatia Sangeeta N. | — | S | -266 | 500 | ~$0.1M |
| 2/11/2026 | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | S | -466 | 460.43 | ~$0.2M |
| 2/11/2026 | Bunnage Mark E. | EVP, Chief Scientific Officer | S | -2021 | 460.43 | ~$0.9M |
| 2/11/2026 | Biller Jonathan | EVP and Chief Legal Officer | S | -1925 | 460.43 | ~$0.9M |
| 2/11/2026 | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off. | S | -1751 | 460.43 | ~$0.8M |
| 2/11/2026 | Ambrose Kristen | SVP & Chief Accounting Officer | S | -1376 | 460.43 | ~$0.6M |
| 1/7/2026 | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | S | -4500 | 474.99 | ~$2.1M |
| 1/6/2026 | WAGNER CHARLES F JR | EVP, CO & FO | S | -9532 | 461 | ~$4.4M |
| 12/3/2025 | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | S | -4500 | 449.99 | ~$2.0M |
| 12/3/2025 | LEIDEN JEFFREY M | Executive Chairman | 12 reported sale rows | 63781 | — | ~$28.7M |
| 12/3/2025 | LEIDEN JEFFREY M | Executive Chairman | S | -2320 | 448.78 | ~$1.0M |
| 12/3/2025 | LEIDEN JEFFREY M | Executive Chairman | S | -5880 | 449.84 | ~$2.6M |
| 12/3/2025 | LEIDEN JEFFREY M | Executive Chairman | S | -5809 | 451.2 | ~$2.6M |
| 12/3/2025 | LEIDEN JEFFREY M | Executive Chairman | S | -15681 | 452.2 | ~$7.1M |
| 12/3/2025 | LEIDEN JEFFREY M | Executive Chairman | S | -10360 | 453.34 | ~$4.7M |
| 12/3/2025 | LEIDEN JEFFREY M | Executive Chairman | S | -2070 | 455.22 | ~$0.9M |
| 12/3/2025 | LEIDEN JEFFREY M | Executive Chairman | S | -4469 | 440.4 | ~$2.0M |
| 12/3/2025 | LEIDEN JEFFREY M | Executive Chairman | S | -1320 | 441.26 | ~$0.6M |
| 12/3/2025 | LEIDEN JEFFREY M | Executive Chairman | S | -2469 | 443.21 | ~$1.1M |
| 12/3/2025 | LEIDEN JEFFREY M | Executive Chairman | S | -4352 | 444.36 | ~$1.9M |
| 12/3/2025 | LEIDEN JEFFREY M | Executive Chairman | S | -7899 | 445.56 | ~$3.5M |
| 12/3/2025 | LEIDEN JEFFREY M | Executive Chairman | S | -1152 | 447.05 | ~$0.5M |
| 12/3/2025 | WAGNER CHARLES F JR | EVP, CO & FO | S | -7000 | 451 | ~$3.2M |
| 12/3/2025 | Biller Jonathan | EVP and Chief Legal Officer | S | -347 | 449 | ~$0.2M |
| 11/17/2025 | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off. | S | -2500 | 434.58 | ~$1.1M |
| 11/14/2025 | LEIDEN JEFFREY M | Executive Chairman | 3 reported sale rows | 53604 | — | ~$23.6M |
| 11/14/2025 | LEIDEN JEFFREY M | Executive Chairman | S | -32234 | 440.3 | ~$14.2M |
| 11/14/2025 | LEIDEN JEFFREY M | Executive Chairman | S | -21330 | 441.35 | ~$9.4M |
| 11/14/2025 | LEIDEN JEFFREY M | Executive Chairman | S | -40 | 442 | ~$18K |
| 11/13/2025 | LEIDEN JEFFREY M | Executive Chairman | 2 reported sale rows | 19688 | — | ~$8.7M |
| 11/13/2025 | LEIDEN JEFFREY M | Executive Chairman | S | -18528 | 440.22 | ~$8.2M |
| 11/13/2025 | LEIDEN JEFFREY M | Executive Chairman | S | -1160 | 441.05 | ~$0.5M |
| 10/2/2025 | Biller Jonathan | EVP and Chief Legal Officer | S | -694 | 404.21 | ~$0.3M |
| 8/27/2025 | Bhatia Sangeeta N. | — | S | -266 | 386.69 | ~$0.1M |
| 8/6/2025 | Kewalramani Reshma | CEO & President | 2 reported purchase rows | 10000 | — | ~$3.9M |
| 8/6/2025 | Kewalramani Reshma | CEO & President | P | 5710 | 389.95 | ~$2.2M |
| 8/6/2025 | Kewalramani Reshma | CEO & President | P | 4290 | 389.08 | ~$1.7M |
| 8/6/2025 | SACHS BRUCE I | — | 2 reported purchase rows | 5000 | — | ~$1.9M |
| 8/6/2025 | SACHS BRUCE I | — | P | 3366 | 389.84 | ~$1.3M |
| 8/6/2025 | SACHS BRUCE I | — | P | 1634 | 389.36 | ~$0.6M |
| 5/15/2025 | ALTSHULER DAVID | EVP, Chief Scientific Officer | S | -52 | 424.69 | ~$22K |
| 5/2/2025 | Bhatia Sangeeta N. | — | S | -400 | 505.86 | ~$0.2M |
| 3/13/2025 | ALTSHULER DAVID | EVP, Chief Scientific Officer | S | -3231 | 510 | ~$1.6M |
| 3/10/2025 | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | S | -3242 | 499.99 | ~$1.6M |
| 3/10/2025 | ALTSHULER DAVID | EVP, Chief Scientific Officer | S | -3231 | 500 | ~$1.6M |
| 3/10/2025 | WAGNER CHARLES F JR | EVP & Chief Financial Officer | S | -3298 | 500 | ~$1.6M |
| 3/4/2025 | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | S | -4058 | 485.49 | ~$2.0M |
| 3/3/2025 | ALTSHULER DAVID | EVP, Chief Scientific Officer | S | -3231 | 490 | ~$1.6M |
| 2/27/2025 | ALTSHULER DAVID | EVP, Chief Scientific Officer | S | -1272 | 480 | ~$0.6M |
| 2/27/2025 | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | S | -530 | 475.34 | ~$0.3M |
| 2/27/2025 | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off. | S | -2650 | 475.34 | ~$1.3M |
| 2/25/2025 | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | S | -354 | 480.95 | ~$0.2M |
| 2/25/2025 | ALTSHULER DAVID | EVP, Chief Scientific Officer | S | -848 | 480.95 | ~$0.4M |
| 2/25/2025 | Ambrose Kristen | SVP & Chief Accounting Officer | S | -884 | 480.95 | ~$0.4M |
| 2/25/2025 | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off. | S | -1767 | 480.95 | ~$0.8M |
| 2/20/2025 | ALTSHULER DAVID | EVP, Chief Scientific Officer | S | -1111 | 480 | ~$0.5M |
| 2/18/2025 | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | S | -244 | 455.06 | ~$0.1M |
| 2/18/2025 | Biller Jonathan | EVP and Chief Legal Officer | S | -1657 | 455.06 | ~$0.8M |
| 2/18/2025 | Ambrose Kristen | SVP & Chief Accounting Officer | S | -671 | 455.06 | ~$0.3M |
| 2/11/2025 | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | S | -310 | 459.83 | ~$0.1M |
| 2/11/2025 | Biller Jonathan | EVP and Chief Legal Officer | S | -3433 | 459.87 | ~$1.6M |
| 2/11/2025 | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off. | S | -1747 | 459.83 | ~$0.8M |
| 2/11/2025 | Ambrose Kristen | SVP & Chief Accounting Officer | S | -1376 | 459.83 | ~$0.6M |
| 11/15/2024 | ALTSHULER DAVID | EVP, Chief Scientific Officer | S | -15 | 478.56 | ~$7K |
| 11/11/2024 | WAGNER CHARLES F JR | EVP & Chief Financial Officer | S | -3000 | 518.27 | ~$1.6M |
| 11/8/2024 | Kewalramani Reshma | CEO & President | S | -15198 | 515 | ~$7.8M |
| 10/2/2024 | Biller Jonathan | EVP and Chief Legal Officer | S | -999 | 461.66 | ~$0.5M |